LAS VEGAS - January 6, 2025 (NEWMEDIAWIRE) - Femto Technologies Inc. (Nasdaq: BCAN) ("Femto" or the "Company"), a Femtech pioneer and the creator of Sensera, a feminine wellness product, has been honored by the CES Innovation Awards(R) 2025 in the AI category.
Femto's Sensera, an Advanced Feminine Wellness Device, Leverages its AI and Machine Learning Technology to Achieve Enhanced Comfort and Wellness with a Unique Personalization Experience.
The CES Innovation Awards(R) 2025 program received a record number of submissions over 3400.
The CES Innovation Awards program, owned and produced by the Consumer Technology Association (CTA)(R), is an annual competition honoring outstanding design and engineering in 33 consumer technology product categories. An elite panel of industry expert judges, including members of the media, designers, engineers, and more, reviewed submissions based on innovation, engineering and functionality, aesthetic, and design.
Femto's proprietary technology enables Sensera, a fem-tech device, to provide a unique experience designed to adapt to a woman's changing needs over time, using AI, machine learning and biofeedback sensors.
Sensera features the brand's proprietary technology, Smart Release System (SRS) along with biofeedback sensors, machine learning and artificial intelligence, personalizing the feminine usability experience, bridging the gap between wellness and pleasure. Product and additional capsules are available for pre-order now on the company's website.
"We are honored to be recognized in the AI category by CES Innovation Awards," said Yftah Ben Yaackov, CEO of Femto. "We have been working tirelessly to embed Femto's state-of-the-art technology in Sensera, our feminine wellness device that we are proud to bring to market."
Sensera's Medical Advisor, Urogynecologist, Reconstructive Pelvic Surgeon, and Sexual Medicine Specialist, Dr. Alexandra Dubinskaya, said: "Sensera is on a mission to use technology to listen to a woman's body and adapt to her changing needs. Understanding that there are strong connections between pleasure and wellness (including the connection between the physical and the emotional) and how they relate to overall intimacy experience is not something brands and device creators generally understand. Today that changes thanks to Femto's Sensera."
How It Works:
Sensera's feminine wellness device is made from soft, medical-grade silicone and features a Y-shaped, ergonomic design. Women can choose a capsule (pleasure or wellness) and insert one of the interchangeable pods into the device with a simple twist. Once the session starts, Sensera's proprietary SRS technology utilizes biofeedback sensors that track key body metrics, heart rate, and pelvic floor muscle contractions, to adapt to women's personal needs and preferences.
A corresponding iOS app enables users to create personal customized programs, enhancing its performance and ability to "build" on previous sessions.
Under strict privacy protocols, women have the choice to support women's wellness by sharing their likes, dislikes and feedback to create better, more personalized wellness programs for all. Sensera also offers device-only mode and machine learning-only use. Sensera's AI capabilities are designed to become more advanced in correlation to the increased volume of users and magnitude of fed data.
Sensera's feminine wellness device includes a charging cable, storage sachet, quick start guide and three interchangeable pods: two pleasure; one wellness. It will be available for pre-order in Q1 at www.senserawellness.com. Additional capsules can be purchased separately as a one-time order or via subscription. Pre-orders are scheduled to ship early Q2 2025.
The CES Innovation Awards 2025 honorees, including product descriptions and photos, can be found at CES.tech/innovation. Many honorees will showcase their winning products in the CES Innovation Awards Showcase at CES 2025.
About CES(R):
CES is the most powerful tech event in the world the proving ground for breakthrough technologies and global innovators. This is where the world's biggest brands do business and meet new partners, and the sharpest innovators hit the stage. Owned and produced by the Consumer Technology Association (CTA)(R), CES features every aspect of the tech sector. CES 2025 takes place Jan. 7-10, 2025, in Las Vegas. Learn more at CES.tech and follow CES on social.
ABOUT SENSERA
Sensera is a feminine wellness device on a mission to bridge the gap between feminine pleasure and wellness, providing a holistic self-care experience that adapts to a woman's changing needs. Sensera utilizes Femto's proprietary Smart Release System (SRS) technology, including machine learning and AI, to enhance feminine wellness. Sensera is a CES Innovation Awards(R) 2025 Honorary in the AI category.
Femto Technologies Inc. (Nasdaq: BCAN), previously known as BYND Cannasoft Enterprises Inc., is a public Femtech company, pioneering a transformative change in the sphere of female wellness. Its proprietary Smart Release System (SRS technology) is embedded in Sensera, which has been named CES Innovation Awards(R) 2025 honoree in the AI category. Femto's SRS technology is driving its R&D activities and product manufacturing for a variety of Femtech products.
The devices described in this news release are concept devices that are in the first stage of development and will be subject to testing, experiments and regulatory approvals and therefore there is no certainty that they will eventually be marketed.
This press release includes certain statements that may be deemed "forward-looking statements" within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended and under Canadian securities laws. When used in this press release, the words "may", "would", "could", "will", "intend", "plan", "anticipate", "believe", "estimate", "expect" and similar expressions are intended to identify forwardlooking statements. Such statements are subject to certain risks and uncertainties, and actual circumstances, events or results may differ materially from those projected in such forward-looking statements.
Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance, and actual events or developments may differ materially from those in forward-looking statements. Such forward-looking statements necessarily involve known and unknown risks and uncertainties, which may cause the Company's actual performance and financial results in future periods to differ materially from any projections of future performance or results expressed or implied by such forward-looking statements. Such statements reflect the Company's current views with respect to future events and are subject to such risks and uncertainties. Many factors could cause actual results to differ materially from the statements made, including future financial performance, unanticipated regulatory requests and delays, final patents approval, timing of the Sensera pre-order and those factors discussed in filings made by the company with the Canadian securities regulatory authorities, including (without limitation) in the company's management's discussion and analysis for the year ended December 31, 2023 and annual information form dated April 2, 2024, which are available under the company's profile at www.sedarplus.ca, and in the Company's Annual Report on Form 20-F for the year then ended that was filed with the U.S. Securities and Exchange Commission on April 3, 2024. Should one or more of these factors occur, or should assumptions underlying the forward-looking statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, or expected. We do not intend and do not assume any obligation to update these forwardlooking statements, except as required by law. Any such forward-looking statements represent management's estimates as of the date of this press release. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change. Shareholders are cautioned not to put undue reliance on such forwardlooking statements.
